In addition, the candidate genes SERPINB5 (P = 0.008) and TM4SF4 (P = 0.043), which were upregulated in the mesenchymal tumor cells, correlated with a significantly decreased survival potential in patients with higher expression levels (Fig. 8D,E). This evidence concerns the gene SERPINB5 and neoplasm.